RA Capital Management’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

RA Capital Management’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-7,856,612	Closed	-$365M	–	68
2023 Q2	$365M	Hold	7,856,612	–	–	6.89%	4
2023 Q1	$225M	Buy	7,856,612 +1,007,701	+15%	+$29.8M	5.1%	3
2022 Q4	$214M	Buy	6,848,911 +1,640,000	+31%	+$53.5M	4.33%	4
2022 Q3	$106M	Hold	5,208,911	–	–	2.25%	12
2022 Q2	$80.8M	Hold	5,208,911	–	–	2.16%	14
2022 Q1	$99.6M	Hold	5,208,911	–	–	2.17%	11
2021 Q4	$132M	Hold	5,208,911	–	–	2.32%	10
2021 Q3	$171M	Buy	+5,208,911	New	+$177M	2.36%	12

RA Capital Management's DICE Position: Q3 2023 in Review

RA Capital Management sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 7,856,612 shares — an estimated $365M sold.

RA Capital Management first reported a position in DICE in Q3 2021 and held it in 8 quarters. The position peaked at $365M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

RA Capital Management reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
RA Capital Management sold 7,856,612 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $365M.
RA Capital Management first reported a position in DICE Therapeutics, Inc. Common Stock in Q3 2021 and held it in 8 quarters.
RA Capital Management's DICE Therapeutics, Inc. Common Stock position peaked at $365M in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on RA Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.